{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:00:29Z","timestamp":1790629229149,"version":"4.1.0"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Graves\u2019 disease (GD) is an autoimmune disorder that results in hyperthyroidism, in which the immune system mistakenly targets the thyroid gland, causing it to produce excessive amounts of thyroid hormones. Genetic predisposition, environmental factors such as infections and stress, disruptions in the gut microbiome, excessive iodine intake, and epigenetic changes have all been implicated in the development of GD. The recent pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) posed a serious global health crisis. The emergence of COVID-19 vaccines has been pivotal in combating the viral infection and its spread. However, reports of rare adverse events, including the development of autoimmune disorders such as GD following vaccination, have raised concerns. Autoimmune factors play a critical role in the pathogenesis of GD, particularly through the production of autoantibodies targeting the thyroid gland. In this review, reported cases are critically analyzed to elucidate commonalities and potential triggers for the development of this autoimmune disorder, highlighting the vital role of autoimmune mechanisms in inducing GD. We also discuss the molecular mechanisms underlying vaccine-induced autoimmunity, including antigen presentation, bystander activation, molecular mimicry, and the induction of inflammatory factors following vaccination. Understanding these mechanisms in COVID-19 vaccine-induced GD could enhance patient care and guide vaccination policies.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1699210","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:20:07Z","timestamp":1764739207000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 vaccine-induced autoimmune hyperthyroidism: Graves\u2019 disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Avaniyapuram Kannan","family":"Murugan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"B1","unstructured":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"B3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12020-023-03415-6","article-title":"Potential impacts of SARS-CoV-2 on parathyroid: current advances and trends","volume":"81","author":"Murugan","year":"2023","journal-title":"Endocrine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02770-6","article-title":"SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves\u2019 disease","volume":"73","author":"Murugan","year":"2021","journal-title":"Endocrine"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S332705","article-title":"SARS-coV-2: emerging role in the pathogenesis of various thyroid diseases","volume":"14","author":"Murugan","year":"2021","journal-title":"J Inflammation Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.11.009","article-title":"Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis","volume":"114","author":"Zheng","year":"2022","journal-title":"Int J Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0001917","DOI":"10.1371\/journal.pgph.0001917","article-title":"Prevalence of long COVID decreases for increasing COVID-19 vaccine uptake","volume":"3","author":"De Domenico","year":"2023","journal-title":"PloS Glob Public Health"},{"key":"B9","unstructured":"COVID-19 vaccine data"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.01.100","article-title":"COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals","volume":"42","author":"Faksova","year":"2024","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0142","article-title":"Two cases of graves\u2019 Disease following SARS-coV-2 vaccination: an autoimmune\/inflammatory syndrome induced by adjuvants","volume":"31","author":"Vera-Lastra","year":"2021","journal-title":"Thyroid"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11111642","article-title":"Chronic fatigue and dysautonomia following COVID-19 vaccination is distinguished from normal vaccination response by altered blood markers","volume":"11","author":"Semmler","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1101\/2023.11.09.23298266","article-title":"Post-vaccination syndrome: A descriptive analysis of reported symptoms and patient experiences after covid-19 immunization","volume":"10","author":"Krumholz","year":"2023","journal-title":"medRxiv"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2022.04.007","article-title":"Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis","volume":"28","author":"Trougakos","year":"2022","journal-title":"Trends Mol Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.3.2134","article-title":"Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo","volume":"181","author":"Appledorn","year":"2008","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab465","article-title":"Circulating severe acute respiratory syndrome coronavirus 2 (SARS-coV-2) vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients","volume":"74","author":"Ogata","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746021","article-title":"Persistence of SARS coV-2 S1 protein in CD16+ Monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection","volume":"12","author":"Patterson","year":"2022","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-021-02696-0","article-title":"Could SARS-coV-2 spike protein be responsible for long-COVID syndrome","volume":"59","author":"Theoharides","year":"2022","journal-title":"Mol Neurobiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/23247096211063356","article-title":"Graves disease following the SARS-coV-2 vaccine: case series","volume":"9","author":"Weintraub","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-023-09848-8","article-title":"The genetics of Graves\u2019 disease","volume":"25","author":"Grixti","year":"2024","journal-title":"Rev Endocr Metab Disord"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2174\/138920211798120772","article-title":"The genetic basis of Graves\u2019 disease","volume":"12","author":"P\u0142oski","year":"2011","journal-title":"Curr Genomics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/JME-20-0078","article-title":"Graves\u2019 disease: introducing new genetic and epigenetic contributors","volume":"66","author":"Razmara","year":"2021","journal-title":"J Mol Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1365-2249.2012.04646.x","article-title":"Association of polymorphisms in DNMT1, DNMT3A, DNMT3B, MTHFR and MTRR genes with global DNA methylation levels and prognosis of autoimmune thyroid disease","volume":"170","author":"Arakawa","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaut.2015.09.006","article-title":"Epigenetic profiling in CD4+ and CD8+ T cells from Graves\u2019 disease patients reveals changes in genes associated with T cell receptor signaling","volume":"67","author":"Limbach","year":"2016","journal-title":"J Autoimmun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2020.100608","article-title":"Correlation of circulating miRNA-146a-5p and let-7b expression with thyroid-stimulating hormone receptor antibody in patients with graves\u2019 disease","volume":"19","author":"Al-Heety","year":"2020","journal-title":"Gene Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03744.x","article-title":"A RNA transcript (Heg) in mononuclear cells is negatively correlated with CD14 mRNA and TSH receptor autoantibodies","volume":"154","author":"Christensen","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5402\/2011\/287052","article-title":"Decrease in TSH Receptor Autoantibodies during Antithyroid Treatment: Relationship with a Long Noncoding Heg RNA and Cdk1 mRNA in Mononuclear Cells","volume":"2011","author":"Christensen","year":"2011","journal-title":"ISRN Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.110756","article-title":"Thyrocyte-derived exosome-targeted dendritic cells stimulate strong CD4+ T lymphocyte responses","volume":"506","author":"Cui","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1417302","article-title":"Causal effects of post-traumatic stress disorder on autoimmune thyroid disease: insights from mendelian randomization","volume":"15","author":"Chen","year":"2024","journal-title":"Front Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.04.005","article-title":"The role of stress in the mosaic of autoimmunity: An overlooked association","volume":"17","author":"Sharif","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2016.31.2.213","article-title":"Clinical relevance of environmental factors in the pathogenesis of autoimmune thyroid disease","volume":"31","author":"Wiersinga","year":"2016","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clim.2017.07.001","article-title":"The microbiota and autoimmunity: Their role in thyroid autoimmune diseases","volume":"183","author":"K\u00f6hling","year":"2017","journal-title":"Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2184","article-title":"Identification of outer membrane porin f protein of Yersinia enterocolitica recognized by antithyrotopin receptor antibodies in Graves\u2019 disease and determination of its epitope using mass spectrometry and bioinformatics tools","volume":"95","author":"Wang","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-014-0640-6","article-title":"Gut microbe analysis between hyperthyroid and healthy individuals","volume":"69","author":"Zhou","year":"2014","journal-title":"Curr Microbiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2174\/1871530319666190930110605","article-title":"Our little friends with big roles: alterations of the gut microbiota in thyroid disorders","volume":"20","author":"Ejtahed","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10295-016-1760-8","article-title":"Linkages of Firmicutes and Bacteroidetes populations to methanogenic process performance","volume":"43","author":"Chen","year":"2016","journal-title":"J Ind Microbiol Biotechnol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1089\/chi.2018.0040","article-title":"Childhood obesity and firmicutes\/bacteroidetes ratio in the gut microbiota: A systematic review","volume":"14","author":"Indiani","year":"2018","journal-title":"Child Obes"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0193","article-title":"Gut microbiota may play a significant role in the pathogenesis of graves\u2019 Disease","volume":"31","author":"Jiang","year":"2021","journal-title":"Thyroid"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.24151","article-title":"Molecular alteration analysis of human gut microbial composition in graves\u2019 disease patients","volume":"14","author":"Ishaq","year":"2018","journal-title":"Int J Biol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20191242","article-title":"Intestinal microbiota changes in Graves\u2019 disease: a prospective clinical study","volume":"40","author":"Yan","year":"2020","journal-title":"Biosci Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa511","article-title":"Gut dysbiosis contributes to the imbalance of treg and th17 cells in graves\u2019 Disease patients by propionic acid","volume":"105","author":"Su","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/s1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun Rev"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-1010-9","article-title":"Alterations in the intestinal microbiota of patients with severe and active Graves\u2019 orbitopathy: a cross-sectional study","volume":"42","author":"Shi","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"B46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/nyas.14041","article-title":"Excess iodine intake: sources, assessment, and effects on thyroid function","volume":"1446","author":"Farebrother","year":"2019","journal-title":"Ann N Y Acad Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2014.29.3.240","article-title":"Effects of increased iodine intake on thyroid disorders","volume":"29","author":"Sun","year":"2014","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01713","article-title":"Role of selenium intake for risk and development of hyperthyroidism","volume":"104","author":"Wang","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041452","article-title":"The role of vitamin D in autoimmune thyroid diseases: A narrative review","volume":"12","author":"Czarnywojtek","year":"2023","journal-title":"J Clin Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.48.63","article-title":"High prevalence of vitamin D deficiency in Japanese female patients with Graves\u2019 disease","volume":"48","author":"Yamashita","year":"2001","journal-title":"Endocr J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9789-6","article-title":"Serum vitamin D levels are decreased in patients without remission of Graves\u2019 disease","volume":"43","author":"Yasuda","year":"2013","journal-title":"Endocrine"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9080815","article-title":"Vaccinations and autoimmune diseases","volume":"9","author":"Olivieri","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B53","unstructured":""},{"key":"B54","doi-asserted-by":"publisher","first-page":"e246432","DOI":"10.1136\/bcr-2021-246432","article-title":"Graves\u2019 disease following administration of second dose of SARS-CoV-2 vaccine","volume":"14","author":"Goblirsch","year":"2021","journal-title":"BMJ Case Rep"},{"key":"B55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12020-021-02919-3","article-title":"Occurrence and response to treatment of Graves\u2019 disease after COVID vaccination in two male patients","volume":"75","author":"Di Filippo","year":"2022","journal-title":"Endocrine"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02902-y","article-title":"Graves\u2019 disease following SARS-CoV-2 vaccination","volume":"74","author":"Sriphrapradang","year":"2021","journal-title":"Endocrine"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002059","article-title":"Thyroid eye disease following COVID-19 vaccine in a patient with a history graves\u2019 Disease: A case report","volume":"37","author":"Rubinstein","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02879-8","article-title":"Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves\u2019 disease","volume":"74","author":"Sriphrapradang","year":"2021","journal-title":"Endocrine"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102738","article-title":"A case of Graves\u2019 disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination","volume":"125","author":"Patrizio","year":"2021","journal-title":"J Autoimmun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101108","article-title":"A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 Vaccine","volume":"9","author":"Yamamoto","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02898-5","article-title":"Thyrotoxicosis after COVID-19 vaccination: seven case reports and a literature review","volume":"74","author":"Lee","year":"2021","journal-title":"Endocrine"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.778964","article-title":"Development of graves\u2019 Disease after SARS-coV-2 mRNA vaccination: A case report and literature review","volume":"9","author":"Lui","year":"2021","journal-title":"Front Public Health"},{"key":"B63","doi-asserted-by":"publisher","first-page":"dgac049","DOI":"10.1210\/clinem\/dgac049","article-title":"SARS-CoV-2 vaccine- induced thyroiditis: Safety of Re-vaccinations and Clinical Follow-up","author":"O\u011fuz","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.12890\/2021_002807","article-title":"Recurrence of graves\u2019 Disease (a th1-type cytokine disease) following SARS-coV-2 mRNA vaccine administration: A simple coincidence","volume":"8","author":"Pierman","year":"2021","journal-title":"Eur J Case Rep Intern Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102809","article-title":"Relapsed and newly diagnosed Graves\u2019 disease due to immunization against COVID-19: A case series and review of the literature","volume":"128","author":"Bostan","year":"2022","journal-title":"J Autoimmun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.47102\/annals-acadmedsg.2021398","article-title":"Graves\u2019 disease after COVID-19 vaccination","volume":"51","author":"Chua","year":"2022","journal-title":"Ann Acad Med Singap"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2022.02.010","article-title":"SARS-CoV-2 vaccination related hyperthyroidism of graves\u2019 disease","volume":"121","author":"Shih","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac119","article-title":"SARS-CoV-2 mRNA Vaccination and Graves\u2019 Disease: a report of 12 cases and review of the literature","volume":"107","author":"Chee","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-022-01739-0","article-title":"Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion","volume":"11","author":"Pla Peris","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01650-0","article-title":"Two further cases of Graves\u2019 disease following SARS-Cov-2 vaccination","volume":"45","author":"Zettinig","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202204_28500","article-title":"A rare case of grave\u2019s disease after SARS-CoV-2 vaccine: is it an adjuvant effect","volume":"26","author":"Taieb","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e24418","DOI":"10.7759\/cureus.24418","article-title":"Graves\u2019 Disease following COVID-19 vaccination","volume":"14","author":"Singh","year":"2022","journal-title":"Cureus"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.12890\/2022_003275","article-title":"A case of graves\u2019 Disease following vaccination with the oxford-astraZeneca SARS-coV-2 vaccine: case report and review of the literature","volume":"9","author":"Cuenca","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9231-21","article-title":"Graves\u2019 Disease after administration of severe acute respiratory syndrome coronavirus 2 (SARS-coV-2) vaccine in a type 1 diabetes patient","volume":"61","author":"Sakai","year":"2022","journal-title":"Intern Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01863-x","article-title":"SARS-CoV-2 vacine may trigger thyroid autoimmunity: real-life experience and review of the literature","volume":"45","author":"Ruggeri","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e220049","DOI":"10.1530\/ETJ-22-0049","article-title":"New-onset Graves\u2019 disease following SARS- CoV-2 vaccination: a case report","volume":"11","author":"Manta","year":"2022","journal-title":"Eur Thyroid J"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ22-0208","article-title":"Four cases of Graves\u2019 disease following viral vector severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) vaccine","volume":"69","author":"Chaudhary","year":"2022","journal-title":"Endocr J"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911492","article-title":"Two cases of autoimmune thyroid disorders after COVID vaccination in dialysis patients","volume":"23","author":"Lioulios","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12902-023-01387-2","article-title":"Graves\u2019 disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature","volume":"23","author":"Takedani","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"B80","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.4103\/Singaporemedj.SMJ-2021-357","article-title":"Severe Graves\u2019 disease in a child following a single dose of Pfizer-BioNTech SARS-CoV-2 vaccine","volume":"10","author":"Chen","year":"2023","journal-title":"Singapore Med J"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2023-0181","article-title":"Graves\u2019 disease after COVID mRNA vaccination for the first time diagnosed in adolescence-case report. Cause and effect relationship or simple coincidence","volume":"36","author":"Mainieri","year":"2023","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v11.i5.1122","article-title":"Thyrotoxicosis in patients with a history of Graves\u2019 disease after SARS-CoV-2 vaccination (adenovirus vector vaccine): Two case reports","volume":"11","author":"Yan","year":"2023","journal-title":"World J Clin cases"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11050934","article-title":"Graves\u2019 Disease after mRNA COVID-19 Vaccination, with the Presence of Autoimmune Antibodies Even One Year Later","volume":"11","author":"Nakamura","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B84","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12902-023-01287-5","article-title":"HLA typing of patients who developed subacute thyroiditis and Graves\u2019 disease after SARS-CoV-2 vaccination: a case report","volume":"23","author":"Yasuda","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2174\/1871530322666220621101209","article-title":"A case report of concurrent graves\u2019 Disease and subacute thyroiditis following SARS-coV-2 vaccination: an autoimmune\/inflammatory syndrome (ASIA)","volume":"23","author":"Ta\u015fkald\u0131ran","year":"2023","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.22038\/AOJNMB.2023.73051","article-title":"Graves\u2019 disease post-COVID-19 m-RNA vaccine in pediatric age group","volume":"12","author":"Al-Jahhafi","year":"2024","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.617089","article-title":"Reaction of human monoclonal antibodies to SARS-coV-2 proteins with tissue antigens: implications for autoimmune diseases","volume":"11","author":"Vojdani","year":"2021","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1058007","article-title":"Effect of SARS-CoV-2 BNT162b2 mRNA vaccine on thyroid autoimmunity: A twelve-month follow-up study","volume":"14","author":"Morita","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01707-0","article-title":"Thyroid as a target of adjuvant autoimmunity\/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves\u2019 disease to silent thyroiditis","volume":"45","author":"Pujol","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103287","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) in 2023","volume":"22","author":"Cohen Tervaert","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101759","article-title":"COVID-19 vaccination and thyroiditis","volume":"37","author":"\u015eendur","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B93","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.phrs.2014.08.002","article-title":"Predicting post-vaccination autoimmunity: who might be at risk","volume":"92","author":"Soriano","year":"2015","journal-title":"Pharmacol Res"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5270.1947","article-title":"Induction of bystander T cell proliferation by viruses and type I interferon in vivo","volume":"272","author":"Tough","year":"1996","journal-title":"Science"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.12.2089","article-title":"T cell stimulation in vivo by lipopolysaccharide (LPS)","volume":"185","author":"Tough","year":"1997","journal-title":"J Exp Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199911)29","article-title":"Bystander activation of CD4(+) T cells can represent an exclusive means of immunopathology in a virus infection","volume":"29","author":"Gangappa","year":"1999","journal-title":"Eur J Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2021.04.010","article-title":"ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients","volume":"191","author":"Ramos","year":"2021","journal-title":"Am J Pathol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101695","article-title":"The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin \u03b15\u03b21 and NF-\u03baB signaling","volume":"298","author":"Robles","year":"2022","journal-title":"J Biol Chem"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur J Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e107183","DOI":"10.1371\/journal.pone.0107183","article-title":"Increased expression of IL-37 in patients with Graves\u2019 disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells","volume":"9","author":"Li","year":"2014","journal-title":"PloS One"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.2.1310","article-title":"IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy","volume":"175","author":"Chen","year":"2005","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1699210\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T05:20:19Z","timestamp":1764739219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1699210\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":103,"alternative-id":["10.3389\/fimmu.2025.1699210"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1699210","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"article-number":"1699210"}}